Printer Friendly

New DTP vaccine licensed.

The Food and Drug Administration has issued a license for a new vaccine against diptheria, tetanus and pertussis (DTP). The new vaccine is produced using purified, inactivated components of the pertussis bacterial organism instead of whole cells. This new vaccine reduces the incidence of redness, swelling and tenderness compared with a whole-cell pertussis DTP vaccine. However, the new vaccine will have no effct on the rarer but more serious side effects of high fever, collapse, persistent crying, or convulsions.

The American Academy of Pediatrics recommends that children routinely receive a five-dose vaccination series against these diseases before age seven. The first three doses, recommended at two, four and six months of age, require the whole-cell pertussis DTP vaccine. The fourth dose is administered at approximately 18 months of age, and the pre-school fifth dose at 4-6 years of age. The new vaccine is approved for children as young as 15 months of age who have previously received 3 or 4 doses of whole-cell pertussis DTP vaccine.
COPYRIGHT 1992 Association of Labor Assistants & Childbirth Educators
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Vaccination News; diptheria, tetanus and pertussis
Publication:Special Delivery
Date:Dec 22, 1992
Words:166
Previous Article:Clinical trials begin for Lyme disease vaccine.
Next Article:The Immunization Resource Guide: Book Reviews and Resources for Parents.
Topics:


Related Articles
Misfiring magic bullets.
Vaccine injury compensation reaches nearly $1 billion.
NEEDLE POINT THERE IS A GOOD REASON TO VACCINATE AGAINST DISEASES NOBODY GETS ANY MORE.
AN OUNCE OF PREVENTION; VACCINATIONS FOR KIDS CAN BE LIFESAVERS.
New vaccines can keep whooping cough in check.
Haemophilus influenzae type b reemergence after combination immunization.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters